Fingerprint
Dive into the research topics of 'A pilot study of the pan-class I PI3K inhibitor buparlisib in combination with cetuximab in patients with recurrent or metastatic head and neck cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically